DOE Isotope Program Joins Global Leaders in Paris to Address Medical Radioisotope Supply

Representatives from the DOE Isotope Program (DOE IP) attended the 2nd International Workshop on Medical Radioisotope Supply, held on October 24-25, 2024, in Paris, France. This event, co-organized by the DOE Isotope Program, the Nuclear Energy Agency, and the European Commission’s Joint Research Centre, brought together governmental decision-makers, industry leaders, healthcare organizations, and researchers to discuss the future of medical radioisotope supply.

The workshop covered several essential areas, including:

• The role and challenges of innovative medical radioisotopes such as lutetium-177 and actinium-225.
• Strengthening supply chain resiliency by better understanding and monitoring supply and demand for these critical materials.
• Infrastructure needs across the medical sector to support a secure and reliable radioisotope supply.

The DOE IP remains committed to advancing medical radioisotope research and fostering collaboration to ensure reliable and sustainable access to these vital resources.